We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GC Medical Science corp.

Download Mobile App




Global Medical Display Market to Reach USD 2 Billion by 2023

By HospiMedica International staff writers
Posted on 21 Mar 2018
The global medical display market is expected to grow at a CAGR of 4.6% from an estimated USD 1.86 billion in 2018 to USD 2.33 billion by 2023, driven by the growing adoption of hybrid operating rooms (ORs), short replacement cycle of medical displays, increasing preference for minimally invasive treatments, and rising number of diagnostic imaging centers.

These are the latest findings of MarketsandMarkets (Northbrook, IL, USA), a global market research company.

On the basis of technology, the LED-backlit LCD displays segment held the largest share of the global medical display market in 2017 due to the high-quality medical images, high power efficiency, long lifespan, and better return on investment offered by LED-backlit LCDs in comparison to CCFL. More...
Based on display color, the color displays segment accounted for the largest share of the medical display market in 2017, driven by the increasing adoption of color displays owing to their features such as high-quality images and multi-modality capability.

On the basis of panel size, the under 22.9-inch panels segment accounted for the largest share of the global medical display market. The growth of this market segment is being driven mainly by advancements in miniature circuits, microcontroller functions, front-end amplification, and wireless data transmission. Based on application, the diagnostic application segment held the largest share of medical display market in 2017, led by the rapidly increasing prevalence of diseases such as cancer and growing number of patients being screened using imaging systems.

Geographically, North America accounted for the largest share of the global medical display market in 2017, followed by Europe. The large market share of the North American region is primarily due to the high penetration of advanced technologies such as hybrid OR technologies, increasing volume of medical screening due to rising incidence/prevalence of various diseases, and replacement of older technologies with advanced display technologies such as OLED.

Related Links:
MarketsandMarkets


Platinum Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Gold Member
Enteral Feeding Pump
SENTINELplus
Pulmonary Ventilator
OXYMAG
Cardiograph Device
PageWriter TC35
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Professor Bumsoo Han and postdoctoral researcher Sae Rome Choi of Illinois co-authored a study on using DNA origami to enhance imaging of dense pancreatic tissue (Photo courtesy of Fred Zwicky/University of Illinois Urbana-Champaign)

DNA Origami Improves Imaging of Dense Pancreatic Tissue for Cancer Detection and Treatment

One of the challenges of fighting pancreatic cancer is finding ways to penetrate the organ’s dense tissue to define the margins between malignant and normal tissue. Now, a new study uses DNA origami structures... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.